A cancer diagnosis is one of the most frightening experiences a person can face. Beyond the medical and emotional challenges, the financial implications of cancer treatment in South Africa — particularly chemotherapy — can be overwhelming without the right information. This 2026 guide explains the real cost of chemotherapy in South Africa, what medical aid schemes cover, what patients pay out of pocket, and which hospitals and oncology centres provide the best combination of clinical quality and financial accessibility.
How Chemotherapy Is Funded in South Africa
Chemotherapy funding in South Africa depends on your insurance status and the specific drug regimen prescribed. For patients on registered medical aid schemes, most chemotherapy drugs are covered either as in-hospital benefits (for IV chemotherapy administered during hospital admission or day treatment) or under the oncology benefit and chronic medicine benefit for oral chemotherapy. The Pharmaceutical Benefits Scheme (PBS) equivalent in South Africa is the Medical Schemes Act formulary system — schemes must cover all chemotherapy drugs listed as PMB treatments in full. For drugs not listed as PMBs, coverage depends on your specific plan’s oncology benefit limits. Uninsured patients accessing care in public hospitals receive chemotherapy through the state — the essential medicine list and National Cancer Treatment Guidelines — at no charge, subject to availability.
Cancer Chemotherapy Costs at Private Hospitals in South Africa 2026
| Cancer Type / Regimen | Cost per Cycle (ZAR) | Notes |
| Breast cancer (AC-T: doxorubicin, cyclophosphamide, paclitaxel) | R8,000 – R22,000 | Standard adjuvant; 8 cycles total; most costs PMB covered |
| Colorectal cancer (FOLFOX: folinic acid, fluorouracil, oxaliplatin) | R15,000 – R35,000 | 12 cycles typical; oxaliplatin drives cost |
| Lung cancer (carboplatin + paclitaxel) | R18,000 – R40,000 | 4-6 cycles; carboplatin AUC-dosed |
| Lymphoma (CHOP-R: rituximab-based) | R35,000 – R80,000 | Rituximab R25,000+ per dose; high-cost biologic |
| Leukaemia (AML induction: cytarabine + daunorubicin) | R60,000 – R150,000 | Inpatient 7+3 protocol; hospitalisation included |
| Prostate cancer (docetaxel) | R20,000 – R45,000 | 6 cycles; docetaxel price variable |
| Immunotherapy (pembrolizumab/nivolumab) | R60,000 – R120,000 | Per infusion cycle; extremely high cost — PBS access key |
Note: Costs shown are private hospital chemotherapy day treatment costs including drug acquisition, administration, nursing, and pharmacy fees. With medical aid cover, patient out-of-pocket costs are substantially reduced. Total course costs can range from R80,000 to over R1,000,000 depending on drug type and number of cycles.
What Medical Aid Covers for Chemotherapy in South Africa
All registered medical aid schemes must cover chemotherapy for cancers that qualify as Prescribed Minimum Benefits in full — this includes most solid tumour and haematological malignancy diagnoses. In practice, this means your scheme must fund the standard-of-care chemotherapy regimen for your cancer type at cost, without deducting from your medical savings account or applying co-payments, provided treatment is obtained from a designated service provider. The critical practical steps are to obtain a pre-authorisation number from your scheme before starting chemotherapy, ensure your oncologist is a registered specialist contracted with your scheme, and confirm that your chemotherapy drugs are on your scheme’s formulary or are PMB-level treatments.
High-cost immunotherapy and targeted therapy drugs — including pembrolizumab (Keytruda), nivolumab (Opdivo), trastuzumab (Herceptin), bevacizumab (Avastin), and imatinib (Gleevec) — are increasingly covered by South African medical aids following successful Medicines Control Council (SAHPRA) registration and scheme formulary listings. Discovery Health, Bonitas, and Momentum Health have the most progressive formularies for newer oncology agents in 2026.
Best Oncology Hospitals and Chemotherapy Centres in South Africa 2026
| Hospital / Centre | Location | Oncology Specialty |
| Netcare Milpark Hospital (Disa Oncology) | Johannesburg, GP | Comprehensive chemo day unit, haematology, Gauteng leader |
| Mediclinic Morningside Oncology Centre | Sandton, GP | Multidisciplinary tumour boards, Gamma Knife, radiation + chemo |
| Netcare Christiaan Barnard Memorial | Cape Town, WC | Cape Town private oncology leader, haematology unit |
| Vincent Pallotti Hospital (Cape Town) | Pinelands, WC | Oncology day unit, breast and GI cancer focus |
| Life Entabeni Hospital Oncology | Durban, KZN | KZN private oncology leader, haematology, bone marrow |
| Wits Donald Gordon Medical Centre | Johannesburg, GP | Academic oncology, clinical trials, bone marrow transplant |
| Steve Biko Academic Hospital (Public) | Pretoria, GP | Public oncology centre, PMB chemo access, haematology |
Leading Medical Oncologists in South Africa 2026
| Oncologist | Hospital | City | Specialty |
| Prof. Paul Ruff | Wits Donald Gordon / Wits Oncology | Johannesburg | GI oncology, clinical trials, oncology leadership |
| Prof. Lydia Dreosti | Wits Oncology / Milpark | Johannesburg | GI and lung oncology, immunotherapy |
| Prof. Carol-Ann Benn | Milpark / Breast Unit SA | Johannesburg | Breast oncology, surgical oncology, advocacy |
| Dr Carla Botha | Mediclinic Morningside | Johannesburg | Medical oncology, breast, lung, GI cancers |
| Prof. Judith Jacobson | UCT / Groote Schuur | Cape Town | Haematology oncology, lymphoma, leukaemia |
| Dr Vanessa Vorobiof | Disa Oncology / Netcare | Johannesburg | Medical oncology, breast cancer, immunotherapy |
Financial Assistance for Cancer Chemotherapy Patients in South Africa
- CANSA (Cancer Association of South Africa): financial grants, patient transport, accommodation near treatment centres, and patient navigation support — 0800 226 622 (toll-free)
- Pharmaceutical patient assistance programmes: Roche (trastuzumab, bevacizumab), MSD (pembrolizumab), BMS (nivolumab) offer compassionate use and patient assistance for unaffordable drugs
- Medikredit Oncology Support: financial navigation services helping patients access maximum medical aid oncology benefits
- SASSA disability grants: patients unable to work due to cancer treatment may qualify for temporary disability grants
- Hospice Palliative Care Association of South Africa: free palliative care coordination for advanced cancer patients in all provinces
Frequently Asked Questions
How much does chemotherapy cost in South Africa without medical aid?
Private chemotherapy costs without medical aid vary widely depending on the drug regimen. Standard breast cancer chemotherapy (AC-T protocol) costs approximately R120,000 to R250,000 for the full 8-cycle course at private rates. High-cost immunotherapy (pembrolizumab) can cost R60,000 to R120,000 per cycle — making it unaffordable without insurance. Public hospitals provide chemotherapy free of charge through the essential medicine list for uninsured patients.
Which South African medical aid has the best oncology cover?
Discovery Health Classic Comprehensive and Fedhealth Maxima offer the most comprehensive oncology benefits in 2026, with the highest oncology benefit limits, the most progressive drug formularies including newer immunotherapy agents, and proactive disease management programmes. Bonitas BonComplete and Momentum Summit Series also provide strong oncology cover at slightly lower premiums.
Is immunotherapy covered by medical aid in South Africa?
Coverage of immunotherapy — particularly pembrolizumab (Keytruda) and nivolumab (Opdivo) — varies by scheme and indication. SAHPRA-registered indications for checkpoint inhibitors are increasingly being added to scheme formularies. Discovery Health and Bonitas have the most progressive immunotherapy formulary inclusions in 2026. Pre-authorisation is always required and clinical motivation from your oncologist is essential for approval.
Conclusion
Cancer chemotherapy in South Africa in 2026 is well-served by both the private and public sectors. With appropriate medical aid cover — particularly Discovery, Fedhealth, or Bonitas comprehensive plans — most standard chemotherapy and an increasing range of immunotherapy agents are covered through PMBs or scheme oncology benefits. For uninsured patients, CANSA financial support and public oncology centres at academic hospitals provide access to essential treatment. Always obtain pre-authorisation before starting chemotherapy, confirm drug formulary coverage with your scheme, and utilise CANSA’s patient navigation services to access all available financial support.